ANXA10
Annexin A10
Also known as: ANX10_HUMAN, ANX14
Cross-references: UniProt · Ensembl · Human Protein Atlas · GeneCards · NCBI Gene
Protein identityUniProt · HPA
- UniProt accession
- Q9UJ72
- Gene
- ANXA10
- Ensembl
- ENSG00000109511
- Chromosome
- 4
- Canonical length
- 324 aa
- Protein class
- Predicted intracellular proteins
- Subcellular location
- Nucleoplasm,Nucleoli,Vesicles
OverviewNCBI Gene
This gene encodes a member of the annexin family. Members of this calcium-dependent phospholipid-binding protein family play a role in the regulation of cellular growth and in signal transduction pathways. The function of this gene has not yet been determined. [provided by RefSeq, Jul 2008]
Canonical amino-acid sequenceUniProt
324 residues, UniProt reviewed canonical sequence.
>Q9UJ72|ANXA10
1 MFCGDYVQGT IFPAPNFNPI MDAQMLGGAL QGFDCDKDML INILTQRCNA QRMMIAEAYQ
61 SMYGRDLIGD MREQLSDHFK DVMAGLMYPP PLYDAHELWH AMKGVGTDEN CLIEILASRT
121 NGEIFQMREA YCLQYSNNLQ EDIYSETSGH FRDTLMNLVQ GTREEGYTDP AMAAQDAMVL
181 WEACQQKTGE HKTMLQMILC NKSYQQLRLV FQEFQNISGQ DMVDAINECY DGYFQELLVA
241 IVLCVRDKPA YFAYRLYSAI HDFGFHNKTV IRILIARSEI DLLTIRKRYK ERYGKSLFHD
301 IRNFASGHYK KALLAICAGD AEDYLocalizationUniProt · AlphaFold · HPA
Whether an antibody against ANXA10 can act on the native protein depends on physical access: surface and secreted proteins are reachable by circulating antibodies, intracellular proteins usually are not.
- Antibody reachability
- Cell surface
- Secreted
- No
- Transmembrane segments
- 0
- Mean surface accessibility (rSASA)
- 0.24
- Highest tissue expression
- 459 nTPM
Expression across tissuesHPA
Tissue
- stomach: 459 nTPM
- urinary bladder: 84 nTPM
- duodenum: 19 nTPM
- testis: 0.9 nTPM
- pancreas: 0.6 nTPM
- gallbladder: 0.4 nTPM
Single-cell type
- foveolar cells: 1,701 nCPM
- parietal cells: 705 nCPM
- mucous neck cells: 588 nCPM
- gastric chief cells: 355 nCPM
- gastric progenitor cells: 297 nCPM
- urothelial cells: 253 nCPM
Immune cell
- basophil: 0 nTPM
- classical monocyte: 0 nTPM
- eosinophil: 0 nTPM
- gdT-cell: 0 nTPM
- intermediate monocyte: 0 nTPM
- MAIT T-cell: 0 nTPM
Brain region
- hypothalamus: 0.2 nTPM
- medulla oblongata: 0.2 nTPM
- midbrain: 0.2 nTPM
- pons: 0.2 nTPM
- spinal cord: 0.2 nTPM
- amygdala: 0.1 nTPM
Genetic constraint and essentialitygnomAD · DepMap
Does the body need this protein intact? Low LOEUF or a strong DepMap dependency means loss or blockade of the protein is likely to be felt.
- gnomAD LOEUF (loss-of-function intolerance)
- 1.24
- gnomAD pLI
- 0
- gnomAD missense Z
- 0.4
- DepMap mean gene effect
- 0.08
- DepMap dependency class
- selective
Cancer expressionTCGA
Across TCGA tumor cohorts, this protein is over-expressed in roughly 3% of surveyed tumor types (aggregate summary; per-cohort expression, alteration, and survival load in the interactive view).
OntologyGO
Molecular functions
Cellular components
Protein domainsUniProt · Pfam · InterPro
KeywordsUniProt
InteractionsUniProt · HPA
Protein binding partners of ANXA10 in the human serome: UniProt-annotated complex subunits plus reported interactors. Each links to its own Seroatlas record.
Antibody and autoantibody relevanceSeroatlas analysis
Seroatlas reads ANXA10 as an antibody target. Whether an autoantibody or antibody against ANXA10 could matter depends on whether native ANXA10 is physically reachable, whether the body needs it intact, and whether it acts in a disease-relevant tissue.
ANXA10 is annotated at the cell surface, where native ANXA10 is exposed to circulating antibodies and is a prime autoantibody target that could block, deplete, or overstimulate it.
Annotation status
The present source text does not explicitly label ANXA10 as an autoantigen. Seroatlas presents hypothesis context only and does not manufacture a known-serology claim.
Loading the interactive Seroatlas protein explorer...